Beatrice Ragnoli

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Chronic Obstructive Pulmonary Disease

Allergic Rhinitis

Top Venues

Journal of clinical medicine

Therapeutic advances in chronic disease

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Beatrice Ragnoli, Federica Fusco, Patrizia Pignatti, Tiziana Cena, Guido Valente, Mario Malerba
Bronchial Progenitor Cells in Obstructive and Neoplastic Lung Disease: A Pilot Study. Journal of clinical medicine 13 (2) (2024)
Beatrice Ragnoli, Federica Fusco, Patrizia Pignatti, Tiziana Cena, Guido Valente, Mario Malerba
Bronchial Progenitor Cells in Obstructive and Neoplastic Lung Disease: A Pilot Study. Journal of clinical medicine 13 (2) (2024)
Beatrice Ragnoli, Tiziana Cena, Patrizia Pochetti, Patrizia Pignatti, Mario Malerba
Lung Involvement in Patients with Ulcerative Colitis: Relationship between Exhaled Nitric Oxide and Lung Function. Journal of clinical medicine 13 (2) (2024)
Beatrice Ragnoli, Tiziana Cena, Patrizia Pochetti, Patrizia Pignatti, Mario Malerba
Lung Involvement in Patients with Ulcerative Colitis: Relationship between Exhaled Nitric Oxide and Lung Function. Journal of clinical medicine 13 (2) (2024)
Beatrice Ragnoli, Alessandro Radaeli, Patrizia Pochetti, Stefano Kette, Jaymin Morjaria, Mario Malerba
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases. Therapeutic advances in chronic disease 14 (2023)
Beatrice Ragnoli, Beatrice Da Re, Alessandra Galantino, Stefano Kette, Andrea Salotti, Mario Malerba
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence. International journal of molecular sciences 24 (10) (2023)
Beatrice Ragnoli, Jaymin Morjaria, Patrizia Pignatti, Paolo Montuschi, Mariangela Barbieri, Lucrezia Mondini, Luca Ruggero, Liliana Trotta, Mario Malerba
Dupilumab and tezepelumab in severe refractory asthma: new opportunities. Therapeutic advances in chronic disease 13 (2022)